Spectral AI seeks add-on Medicare reimbursement for DeepView system

Spectral AI filed an NTAP application with CMS for its DeepView System, seeking add-on Medicare inpatient reimbursement via the alternative pathway. CMS is expected to issue a final decision in August 2027; NTAP status would start in October 2027 if granted. DeepView received FDA De Novo classification in May 2026.